Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories Ltd (RDY)
Price$11.71Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $3.81B | $3.35B | $2.99B | $2.83B | $2.59B | $2.32B | $2.23B | $2.18B | — | — |
| Gross profit | — | $2.23B | $1.96B | $1.70B | $1.50B | $1.41B | $1.25B | $1.21B | $1.17B | — | — |
| Gross margin | — | 58.51% | 58.60% | 56.65% | 53.08% | 54.32% | 53.84% | 54.20% | 53.74% | — | — |
| Research & development | — | $320.0M | $274.0M | $236.0M | $230.0M | $226.0M | $204.0M | $226.0M | $281.0M | — | — |
| Operating expenses | — | $1.39B | $1.15B | $1.00B | $1.11B | $1.08B | $1.03B | $904.0M | $989.0M | — | — |
| Operating income | — | $842.0M | $813.0M | $695.0M | $389.0M | $332.0M | $212.0M | $302.0M | $183.0M | — | — |
| Operating margin | — | 22.09% | 24.27% | 23.23% | 13.77% | 12.80% | 9.15% | 13.57% | 8.39% | — | — |
| EBITDA | — | $1.04B | $991.0M | $849.0M | $545.0M | $507.0M | $377.0M | $478.0M | $363.0M | — | — |
| EBITDA margin | — | 27.34% | 29.58% | 28.38% | 19.29% | 19.55% | 16.28% | 21.48% | 16.64% | — | — |
| Net income | — | $671.0M | $668.0M | $548.0M | $311.0M | $236.0M | $259.0M | $272.0M | $151.0M | — | — |
| Net profit margin | — | 17.61% | 19.94% | 18.32% | 11.00% | 9.10% | 11.18% | 12.22% | 6.92% | — | — |
| Basic EPSper basic share | — | $0.79 | $0.80 | $0.66 | $0.37 | $0.28 | $0.31 | $0.33 | $0.18 | — | — |
| Diluted EPSper diluted share | — | $0.79 | $0.80 | $0.66 | $0.37 | $0.30 | $0.31 | $0.33 | $0.18 | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Robeco Institutional Asset Management B.V. | 18.02M |
MORGAN STANLEY | 10.94M |
BlackRock, Inc. | 10.59M |
ROYAL BANK OF CANADA | 9.21M |
Aikya Investment Management Ltd | 8.49M |
RENAISSANCE TECHNOLOGIES LLC | 7.35M |
DIMENSIONAL FUND ADVISORS LP | 5.31M |
STATE STREET CORP | 4.12M |
JPMORGAN CHASE & CO | 4.07M |
ALLIANCEBERNSTEIN L.P. | 3.73M |
VANGUARD CAPITAL MANAGEMENT LLC | 3.1M |
FRANKLIN RESOURCES INC | 2.84M |
Nuveen, LLC | 2.83M |
BNP PARIBAS FINANCIAL MARKETS | 2.65M |
ACADIAN ASSET MANAGEMENT LLC | 2.26M |
MARSHALL WACE, LLP | 2.03M |
BESSEMER GROUP INC | 1.86M |
AMERICAN CENTURY COMPANIES INC | 1.83M |
UBS Group AG | 1.66M |
SCHRODER INVESTMENT MANAGEMENT GROUP | 1.62M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data